Augtyro

Pharma

BMS bags FDA tumor-agnostic nod to challenge Bayer, Roche

NTRK fusion-positive treatment is a familiar indication to oncologists with offerings from Bayer and Roche, but Bristol Myers' Augtyro boasts a first.

Angus Liu Jun 14, 2024 10:31am

FDA clears Bristol Myers cancer drug from Turning Point buy

Nov 16, 2023 11:10am